Author

S. Meshinchi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

CBFA2T3–GLIS2 establishes transcriptionally permissive enhancer hypermethylation associated with venetoclax response in pediatric AML

Hypermethylated active cis-regulatory elements are identified as C/G-associated states linked to transcriptional dysregulation and venetoclax response to C/G AML.

Arundhati Chavan, R. Ries, Pritam Biswas et al. · bioRxiv · 0 citations

Review Open access Sep 2026

Search for leukemia-restricted targets: a new paradigm for precision immunotherapy in acute myeloid leukemia.

Acute myeloid leukemia (AML) remains a major therapeutic challenge despite remarkable advances in genomic characterization. Although molecular profiling has transformed disease classification and risk stratification, treatment for most patients continues to rely on cytotoxic chemotherapy regimens developed more than 50...

S. Meshinchi, Franco Locatelli · Haematologica · 0 citations